Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 345k | 21.89M | 71.43M | 98.22M | 102.69M | 108.45M | 88.64M | -1.02M |
| Operating Income | -54.68M | -44.59M | -2.05M | 20.2M | 18.72M | 1.93M | -11.67M | -68.88M |
| Pre Tax Income | -53.88M | -42.13M | 1.4M | 24.01M | 22.41M | 6.48M | -118.55M | -72.7M |
| Net Income | -53.76M | -42.7M | 1.57M | 22.07M | 20.89M | 4.73M | -118.79M | -72.7M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -54.54M | -44.59M | -2.32M | 20.2M | 17.89M | 1.93M | -12.42M | -69.36M |
| EBITDA | -54.52M | -44.41M | -1.85M | 20.48M | 19.02M | 2.24M | -11.35M | -68.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.43M | 1.43M | 285k | 22.23M | 380.79M |
| Operating Income | -13.55M | -13.55M | -82.69M | -201.34M | 38.8M |
| Pre Tax Income | -13.72M | -13.72M | -87.93M | -197.6M | 54.3M |
| Net Income | -13.72M | -13.72M | -87.93M | -198.38M | 49.27M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.288 | -2.288 | -3.162 | -2.272 | 0.558 |
| EBIT | -13.56M | -13.56M | -82.74M | -201.34M | 38.8M |
| EBITDA | -13.55M | -13.55M | -82.64M | -200.85M | 39.89M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
